DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

Sarepta Therapeutics

NASDAQ: SRPT

24.40 0.17 (0.70%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SRPT $24.40 0.70%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.01
Previous Close $24.23
Daily Range $23.42 - $24.74
52-Week Range $12.12 - $55.61
Market Cap $921.7M
P/E Ratio -7.37
Dividend (Yield) $0.00 (0.0%)
Volume 1,001,565
Average Daily Volume 1,089,841
Current FY EPS -$3.26

Sector

Healthcare

Industry

Drugs

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website: http://www.sareptatherapeutics.com/

News & Commentary Rss Feed

The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, Ziopharm, and MannKind

Myraid Genetics, Sarepta Therapeutics, Questcor Pharmaceuticals, Ziopharm Oncology, and MannKind top the list of the most shorted biotechs.

Sarepta Therapeutics on Cusp of Huge Eteplirsen News

Sarepta Therapeutics (SRPT) Showing Signs Of Perilous Reversal Today

Why Now Is The Time To Get Behind Sarepta Therapeutics

Prosensa Rises on Encouraging Data - Analyst Blog

Sarepta Therapeutics Inc (SRPT): Today's Featured Drugs Winner

Prosensa Making the Best of Inconsistent Drisapersen Data

Perilous Reversal Stock: Sarepta Therapeutics (SRPT)

Sarepta Therapeutics Inc (SRPT): Today's Featured Drugs Winner

Sarepta Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript

Sector Update: Healthcare Shares Flat to Lower Pre-Market; Pacira Up 5% on Phase 3 Trial Meeting End

Sector Update: Healthcare Shares Flat to Lower Pre-Market; Pacira Up 5% on Phase 3 Trial Meeting Endpoints

See More SRPT News...

SRPT's Top Competitors

SRPT $24.40 (0.70%)
Current stock: SRPT
BIIB $290.54 (-0.32%)
Current stock: BIIB
AMGN $115.46 (-0.07%)
Current stock: AMGN
CELG $141.51 (-0.25%)
Current stock: CELG